PTGES3
Prostaglandin E Synthase 3 (Cytosolic)
Gene Information Card
| Symbol | PTGES3 |
|---|---|
| Full Name | Prostaglandin E Synthase 3 (Cytosolic) |
| Gene Type | Protein coding |
| Chromosomal Location | 12q13.3 |
| NCBI Gene ID | 10728 ncbi.nlm.nih.gov/gene/10728 |
| Ensembl ID | ENSG00000110931 |
| UniProt ID | Q15185 |
| OMIM ID | 607061 |
| HGNC ID | 9599 |
| Aliases | cPGES, p23, TEBP, SRS2, Hsp90 co-chaperone |
Description
PTGES3 encodes the cytosolic prostaglandin E synthase (cPGES), also known as p23, which catalyzes the isomerization of prostaglandin H2 (PGH2) to prostaglandin E2 (PGE2). It functions as a co-chaperone for Hsp90 and is involved in protein folding, steroid hormone receptor signaling, and inflammatory responses. The gene is ubiquitously expressed and plays roles in cancer, immune regulation, and cellular stress.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (breast, colorectal, lung) | Overexpression of PTGES3 increases PGE2 production, promoting tumor growth, angiogenesis, and immune evasion. | PMID: 23455478, COSMIC |
| Inflammatory disorders | Elevated PGE2 synthesis via cPGES contributes to chronic inflammation and pain. | PMID: 14525967 |
| Prostate cancer | PTGES3 upregulation correlates with androgen receptor activity and disease progression. | PMID: 21502544 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Adipose tissue | 12.5 | Medium |
| Brain | 8.3 | Low |
| Breast | 15.2 | Medium |
| Colon | 18.7 | Medium |
| Kidney | 14.1 | Medium |
| Liver | 20.4 | High |
| Lung | 16.9 | Medium |
| Prostate | 22.3 | High |
| Skin | 10.8 | Medium |
| Testis | 25.6 | High |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | 19.5 | Cervical cancer cell line |
| A549 | 17.2 | Lung cancer cell line |
| MCF7 | 21.8 | Breast cancer cell line |
| HCT116 | 23.4 | Colorectal cancer cell line |
| HEK293 | 15.6 | Embryonic kidney cell line |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.314A>G (p.Tyr105Cys) | Missense | <0.1% | Unknown functional impact; reported in COSMIC |
| c.487C>T (p.Arg163Trp) | Missense | <0.1% | Potential loss of co-chaperone activity |
| c.1-?_*_?del | Deletion | Rare | Complete loss of function; observed in cancer samples |
Mutation functional classification
Loss of Function (LOF)
Rare deletions or missense variants impairing Hsp90 binding or catalytic activity.
Gain of Function (GOF)
Not well documented; overexpression is more common in cancer.
Dominant Negative (DN)
No confirmed dominant-negative mutations reported.
View complete mutation data:
Gene Ontology (GO)
| • prostaglandin-E synthase activity | • Hsp90 protein binding |
| • unfolded protein binding | • chaperone cofactor-dependent protein refolding |
| • prostaglandin biosynthetic process | • response to stress |
| • steroid hormone receptor signaling pathway |
Pathways
• Arachidonic acid metabolism
• Prostaglandin synthesis and regulation
• Hsp90 chaperone cycle for steroid hormone receptors (e.g.
• ESR1
• AR)
Protein Summary
The PTGES3 protein (cPGES/p23) is a 160-amino acid cytosolic protein that functions both as a prostaglandin E synthase and as a co-chaperone for Hsp90. It contains a p23 domain that binds Hsp90 and facilitates the maturation of client proteins such as steroid hormone receptors and kinases. The enzyme converts PGH2 to PGE2, a key mediator of inflammation and cancer progression. Post-translational modifications include phosphorylation, which modulates its activity.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PTGES3L Knockout HEK293 Cell Line | EDJ-KQ14954 | Human | 100885848 | Details Get a Quote |
| PTGES3L Knockout HeLa Cell Line | EDJ-KQ44159 | Human | 100885848 | Details Get a Quote |
| PTGES3L Knockout A-549 Cell Line | EDJ-KQ45416 | Human | 100885848 | Details Get a Quote |
| PTGES3L Knockout HCT 116 Cell Line | EDJ-KQ45417 | Human | 100885848 | Details Get a Quote |
| PTGES3 Knockout HEK293 Cell Line | EDJ-KQ51003 | Human | 10728 | Details Get a Quote |
| PTGES3L-AARSD1 Knockout HEK293 Cell Line | EDJ-KQ52517 | Human | 100885850 | Details Get a Quote |
| PTGES3 Knockout HeLa Cell Line | EDJ-KQ55472 | Human | 10728 | Details Get a Quote |
| PTGES3L-AARSD1 Knockout HeLa Cell Line | EDJ-KQ60985 | Human | 100885850 | Details Get a Quote |
| PTGES3 Knockout A-549 Cell Line | EDJ-KQ63958 | Human | 10728 | Details Get a Quote |
| PTGES3L-AARSD1 Knockout A-549 Cell Line | EDJ-KQ69459 | Human | 100885850 | Details Get a Quote |
| PTGES3 Knockout HCT 116 Cell Line | EDJ-KQ72413 | Human | 10728 | Details Get a Quote |
| PTGES3L-AARSD1 Knockout HCT 116 Cell Line | EDJ-KQ77810 | Human | 100885850 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records